Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

Saved in:
Bibliographic Details
Published in:Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2022-10, Vol.89 (5), p.105391-105391, Article 105391
Main Authors: Felten, Renaud, Geoffroy, Marion, Bolko, Loïs, Duret, Pierre-Marie, Desmurs, Marie, Fan, Angélique, Couderc, Marion, Laurent, Messer, Ardizzone, Marc, Ahmed-Yahia, Samira, Javier, Rose-Marie, Meyer, Alain, Chatelus, Emmanuel, Sordet, Christelle, Pijnenburg, Luc, Sibilia, Jean, Soubrier, Martin, Gottenberg, Jacques-Eric, Salmon, Jean-Hugues
Format: Article
Language:English
Subjects:
Antibodies, Viral
Arthritis
bDMARDs
COVID-19
COVID-19 - prevention & control
COVID-19 Vaccines - therapeutic use
Humans
Letter to the Editor
Life Sciences
Serology
T-Lymphocytes
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2022.105391